
Read More
Indian Pharma Major Receives China Approval; Marks Entry Into Chinese Marke...
Lupin received approval from China’s National Medical Products Administration for Oseltamivir Phosph...

Lupin received approval from China’s National Medical Products Administration for Oseltamivir Phosph...

Lupin reported Q4FY26 consolidated profit after tax of Rs 1,413.07 crore on revenue from operations ...

The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales...